|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00775 CKLIFE SCIENCES
Nominal 
0.860 +0.050 (+6.173%) | 2024/12 - Final HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | 353,534 | 514,181 | 363,659 | 423,575 | 530,955 |
| Net Cash from / (used in) Investing Activities | (96,645) | (67,961) | (22,119) | (257,884) | (457,312) |
| Net Cash from / (used in) Financing Activities | (341,975) | (477,953) | (515,340) | (220,081) | 168,742 |
| Increase / (Decrease) in Cash & Cash Equivalents | (85,086) | (31,733) | (173,800) | (54,390) | 242,385 |
| Cash & Cash Equivalents at beginning of period | 664,320 | 691,934 | 890,801 | 958,998 | 696,504 |
| Effect of Foreign Exchange Rate Changes | (25,264) | 4,119 | (25,067) | (13,807) | 20,109 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 553,970 | 664,320 | 691,934 | 890,801 | 958,998 |
| Remarks: | Real time quote last updated: 22/05/2025 17:57 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -126,554 |
| %Change | -- |
| EPS / (LPS) | HKD -0.013 |
| NBV Per Share ($) | HKD 0.365 |